Aggregated News

dna in syringe

Think back to last spring. (You probably don’t want to, but humor me.) Those early months of the coronavirus pandemic in America weren’t all fear and chaos — though there certainly was that. There was also optimism, which, when one looks back on it now, seems completely untethered from reality.

You almost certainly heard it: Flu is worse. We are very, very ready for this. We’re just shutting down for two weeks. Considering our national death toll of more than half a million and counting, the optimism was clearly misplaced. Even so, one rosy prediction came true in a big way.

In March 2020, we were told a vaccine to prevent COVID-19 was a year to 18 months off — even though normal vaccine development takes years, often more than a decade, with no guarantee of success. We still don’t have vaccines to prevent AIDS or childhood RSV infections.

But on November 9th, pharmaceutical companies Pfizer and BioNTech announced that their two-dose vaccine was more than 90 percent effective in preventing COVID-19. Another company, Moderna, soon released similar news.

It...